Genenta Science S.P.A. ADR (GNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 06-2025 | 12-2024 | 06-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,388 | -4,344 | -9,644 | -4,349 | -12,604 |
| Depreciation Amortization | 32 | 16 | 48 | 24 | 46 |
| Accounts payable and accrued liabilities | N/A | 574 | N/A | N/A | N/A |
| Other Working Capital | -1,786 | -2,539 | 1,858 | 1,824 | -452 |
| Other Operating Activity | 1,372 | 33 | 986 | 285 | 883 |
| Operating Cash Flow | $-7,770 | $-6,261 | $-6,752 | $-2,216 | $-12,127 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -5,028 | N/A | N/A | N/A |
| PPE Investments | -9 | -9 | -5 | -2 | -15 |
| Other Investing Activity | -16,446 | 0 | 7,453 | 4,633 | -16,103 |
| Investing Cash Flow | $-16,455 | $-5,037 | $7,448 | $4,631 | $-16,118 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 8,514 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 3,380 | N/A | N/A | N/A |
| Other Financing Activity | 25,216 | 0 | 293 | 292 | 1 |
| Financing Cash Flow | $25,216 | $11,894 | $293 | $292 | $1 |
| Exchange Rate Effect | 80 | 79 | -25 | -17 | -7 |
| Beginning Cash Position | 5,184 | 5,201 | 3,994 | 3,975 | 32,247 |
| End Cash Position | 6,254 | 5,877 | 4,958 | 6,664 | 3,995 |
| Net Cash Flow | $1,070 | $675 | $963 | $2,689 | $-28,252 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,770 | -6,261 | -6,752 | -2,216 | -12,127 |
| Capital Expenditure | N/A | -9 | N/A | N/A | N/A |
| Free Cash Flow | -7,770 | -6,269 | -6,752 | -2,216 | -12,127 |